 |
anthrax immune globulin (human) |
|---|---|
| Trade Name | |
| Orphan Indication | Toxemia associated with inhalational anthrax |
| USA Market Approval | USA |
| USA Designation Date | 2008-07-29 00:00:00 |
| Sponsor | Cangene Corp. - Emergent Biosolutions;155 Innovation Drive, R3T 5Y3; |
| |
anthrax immune globulin (human) |
|---|---|
| Trade Name | |
| Orphan Indication | Toxemia associated with inhalational anthrax |
| USA Market Approval | USA |
| USA Designation Date | 2008-07-29 00:00:00 |
| Sponsor | Cangene Corp. - Emergent Biosolutions;155 Innovation Drive, R3T 5Y3; |